Tests, Treatments, Vaccines: Sorrento Therapeutics Is All In on COVID-19

Brian Orelli, PhD and Corinne Cardina, The Motley Fool
·4-min read

In this Fool Live video, Healthcare and Cannabis Bureau Chief Corinne Cardina and longtime Motley Fool contributor Brian Orelli discuss the massive pivot the biotech has taken. Corinne Cardina: The last stock we're going to dive into deeply is Sorrento Therapeutics. This is its neutralizing antibody treatment.